Next Science
Australia - SydneyBiotechnology
Focus: Next Science is a biotechnology company specializing in anti-biofilm wound and surgical solutions, headquartered in Sydney, Australia. The company develops topical gels and antimicrobial products targeting surgical site infections, chronic wounds, and dermatological conditions.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Next Science
AI assessmentNot HiringNo open roles listed right now. Follow Next Science to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
22 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Benzalkonium Gel
Stable
Peak
Lead product in Phase 4 supporting clinical validation of anti-biofilm mechanism in wound infection.
SurgX Antimicrobial Wound Gel
Help build intelligence for Next Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.